Free Trial

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Revvity Inc. (NYSE:RVTY)

Revvity logo with Medical background

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on June 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on May 28th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
  • Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
  • Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
  • Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
  • Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
  • Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
  • Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
  • Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
  • Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
  • Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.

Revvity Price Performance

RVTY traded down $2.36 on Monday, hitting $90.90. 1,351,207 shares of the company's stock were exchanged, compared to its average volume of 979,713. The firm has a 50-day moving average price of $95.10 and a 200-day moving average price of $103.86. Revvity Inc. has a fifty-two week low of $87.70 and a fifty-two week high of $129.50. The company has a current ratio of 3.58, a quick ratio of 2.99 and a debt-to-equity ratio of 0.41. The stock has a market cap of $10.71 billion, a price-to-earnings ratio of 38.68, a P/E/G ratio of 2.35 and a beta of 0.98.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The firm had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. During the same period in the prior year, the business earned $0.98 EPS. The firm's revenue was up 2.3% on a year-over-year basis. As a group, equities analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Friday, July 18th. Revvity's dividend payout ratio (DPR) is presently 11.91%.

Wall Street Analyst Weigh In

RVTY has been the subject of a number of research reports. Evercore ISI decreased their price target on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. The Goldman Sachs Group cut their price target on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. Wall Street Zen downgraded shares of Revvity from a "buy" rating to a "hold" rating in a report on Friday. Raymond James Financial reissued an "outperform" rating and issued a $120.00 price target (down previously from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Finally, Barclays dropped their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $123.07.

Read Our Latest Research Report on Revvity

Institutional Trading of Revvity

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Janney Montgomery Scott LLC grew its holdings in Revvity by 87.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after buying an additional 3,672 shares in the last quarter. Caprock Group LLC purchased a new stake in shares of Revvity in the fourth quarter worth about $229,000. Trust Point Inc. purchased a new stake in shares of Revvity in the fourth quarter valued at approximately $513,000. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Revvity by 41.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company's stock worth $1,352,000 after buying an additional 3,542 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Revvity by 2.3% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 306,537 shares of the company's stock worth $34,213,000 after acquiring an additional 6,814 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Revvity

(Get Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines